Loading clinical trials...

SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register | Clinical Trials | Clareo Health

COMPLETED

SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register

SchlaHF-XF- Register. Sleep Disordered Breathing in Heart Failure Register

NCT02301689•ResMed

Summary

The SchlaHF XT Registry is a longitudinal study of patients with heart failure (HF). The study aims to understand the importance of diagnosis and treatment of sleep disordered breathing (SDB) on HF with the following questions: How often does SDB occur in HF? What forms of SDB occur and how are they treated? How does SDB develop over time? How does the heart failure therapy affect SDB? What is the treatment adherence of patients treated? Does SBD and its treatment affect the survival of heart failure patients?

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•diagnose chronic heart failure, at least 3 months prior to diagnosis
•Age 18 years
•Signed informed consent

Exclusion Criteria

•Existing Positive Airway Pressure (PAP) therapy or long-term oxygen therapy
•Lack of capacity to consent
•minors
•persons who are housed on judicial or administrative order in an institution
•pregnant and lactating women

Locations (1)

Heart and Diabetes Centre

Bad Oeynhausen, North Rhine-Westphalia, Germany

Key Dates

Start Date

May 1, 2014

Primary Completion Date

December 1, 2017

Completion Date

June 1, 2018

Last Updated

April 9, 2020

Enrollment

4,749

ACTUAL participants

Conditions

Heart Failure (HF)

Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy

NCT07372196

HCM - Hypertrophic CardiomyopathySudden Cardiac Death+3 more

View study

COMPLETED

A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF

NCT04915118

Heart Failure (HF)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register

Inclusion Criteria

Exclusion Criteria

Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy

A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF

Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.

Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.